Biotech · Public company · South San Francisco, CA, US
Electra Therapeutics, Inc.
Ticker ETRA · SEC CIK 0002088082
Track this companyFree. Adds Electra Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline3
- ELA026Phase 3 · Secondary Hemophagocytic Lymphohistiocytosis (sHLH)ClinicalTrials.gov · fetched Nov 12, 2026
- ELA026Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- ELA026Phase 1 · T Cell MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)PHASE1 · RECRUITING · started Feb 17, 2026ClinicalTrials.gov NCT07465835 · fetched Nov 12, 2026
- Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)PHASE2_PHASE3 · RECRUITING · started May 19, 2022ClinicalTrials.gov NCT05416307 · fetched Nov 12, 2026
- Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ELA026 in Single and Multiple Doses in Healthy VolunteersPHASE1 · COMPLETED · started Oct 18, 2021ClinicalTrials.gov NCT05556863 · fetched Nov 12, 2026